IIPR settled all pending litigation with former tenant PharmaCann Inc. on March 13, 2026, a resolution that eliminates the legal uncertainty surrounding the company’s cannabis‑related portfolio. The settlement requires PharmaCann to turn over its properties in New York, Pennsylvania and Ohio by May 20 and May 26, 2026, allowing IIPR to regain control of the sites and re‑lease them to new tenants.
During March 2026, IIPR signed leases covering 122,000 square feet of new space, adding stable triple‑net income to its portfolio. The new agreements demonstrate the company’s continued ability to attract qualified tenants in the regulated cannabis market, reinforcing its strategy of maintaining a high‑quality, income‑generating asset base.
IIPR has already re‑leased three former PharmaCann cultivation assets in Michigan, Massachusetts and Illinois, and has secured leases for three properties that were previously held by Gold Flora in November 2025, January 2026 and March 2026. These re‑tenanting efforts help to stabilize rental income and reduce vacancy risk.
In March 2026, the company experienced rent defaults from Cannabist ($0.6 million) and Battle Green ($0.8 million). IIPR plans to use security deposits to cover the missed payments, underscoring the ongoing credit risk associated with some cannabis tenants.
Financially, IIPR reported Q4 2025 revenue of $66.66 million, a 13.1% decline year‑over‑year, but the company beat earnings expectations with an EPS of $1.06. The company also declared a Q1 2026 dividend of $1.90 per share, reflecting its commitment to shareholder returns. Management emphasized that the settlement and new leases are part of a broader plan to enhance portfolio performance and drive long‑term value.
The settlement removes a potential source of rent uncertainty, while the new leases strengthen the company’s cash‑flow outlook. Together, these developments support IIPR’s strategy of diversifying into life‑science real estate—where it has a $270 million investment commitment—while maintaining a robust cannabis portfolio. However, the recent tenant defaults highlight the need for continued diligence in tenant credit assessment.
Analysts have expressed mixed views; some upgrades have been issued, but overall sentiment remains cautious due to the credit risks in the cannabis sector. Nonetheless, the company’s proactive resolution of litigation and successful lease execution signal confidence in its portfolio management approach.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.